Table 1 Baseline characteristics of the study participants
Item | Group A (n = 93) | Group B (n = 186) | P |
|---|---|---|---|
Age (years) | 37.1 ± 4.8 | 37.2 ± 4.7 | 0.843 |
AMH | 2.9 ± 4.2 | 2.9 ± 2.4 | 0.941 |
BMI (kg/m2) | 22.3 ± 3.1 | 22.8 ± 2.9 | 0.151 |
Infertility type | 1.000 | ||
Primary infertility | 14 (15.1%) | 28 (15.1%) | |
Secondary infertility | 79 (84.9%) | 158 (84.9%) | |
Reason for PGT-A | 1.000 | ||
Advanced age (≥ 38) | 59 (63.4%) | 118 (63.4%) | |
Recurrent miscarriage | 18 (19.4%) | 36 (19.4%) | |
Repeated implantation failure | 7 (7.5%) | 14 (7.5%) | |
PGT-M | 9 (9.7%) | 18 (9.7%) | |
Stimulation protocols | 1.000 | ||
Antagonist protocol | 58 (62.4%) | 116 (62.4%) | |
Agonist protocol | 35 (37.6%) | 70 (37.6%) | |
Number of abortions | 0.8 ± 0.9 | 0.8 ± 0.7 | 1.000 |
Duration of stimulation (days) | 10.0 ± 2.1 | 10.1 ± 1.6 | 0.896 |
Total gonadotrophins dose | 2771.9 ± 816.1 | 2705.2 ± 705.1 | 0.481 |
Antral Follicle Counting | 9.3 ± 4.8 | 10.5 ± 5.9 | 0.079 |